Singular Genomics Systems, Inc.
NASDAQ:OMIC
20.01 (USD) • At close February 20, 2025
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | Singular Genomics Systems, Inc. | 
| Symbool | OMIC | 
| Munteenheid | USD | 
| Prijs | 20.01 | 
| Beurswaarde    |  50,765,770 | 
| Dividendpercentage    |  0% | 
| 52-weken bereik | 5.34 - 23.41 | 
| Industrie | Medical Instruments & Supplies | 
| Sector | Healthcare | 
| CEO | Mr. Andrew Spaventa | 
| Website | https://singulargenomics.com | 
An error occurred while fetching data.
Over Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)








